-
Mashup Score: 5
NIH-funded clinical trial will determine safety, tolerability of experimental drug.
Categories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0
Data are the first nationwide estimates on the incidence of new chronic pain and new high impact chronic pain.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2
Trial will test the experimental vaccine for safety and its ability to induce an immune response.
Categories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 7Writing Respectfully: Person-First and Identity-First Language - 2 year(s) ago
When communicating about disabilities, diseases, and health conditions, it’s important to consider the unique needs and interests of the people experiencing them as part of daily life.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4NIH-funded study highlights the financial toll of health disparities in the United States - 2 year(s) ago
Ground-breaking study provides national and state-level estimates of the economic burden of health disparities by race and ethnicity and educational levels.
Categories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Time to End the Manel Tradition - 2 year(s) ago
NIH director will no longer participate in all-male panels.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Data are the first nationwide estimates on the incidence of new chronic pain and new high impact chronic pain.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1
Trial will test the experimental vaccine for safety and its ability to induce an immune response.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1Scientists release a new human “pangenome” reference - 2 year(s) ago
More complete and sophisticated collection of genome sequences captures significantly more human diversity.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 24
Study suggests adults with both the sleep disorder and COVID may benefit from clinical monitoring.
Categories: Hem/Oncs, Latest HeadlinesTweet
First-in-human trial of oral drug to remove radioactive contamination begins NIH-funded clinical trial will determine safety, tolerability of experimental drug. https://t.co/xfWTvjzHE4